TheraRadar
← Back
Data updated: Mar 29, 2026

PUREPAC PHARM

ImmunologyCardiovascularNeurology
Generics

PUREPAC PHARM is a generic drug manufacturer focused on Immunology, Cardiovascular, Neurology.

1972
Since
62
Drugs
-
Trials
451
Approved (2yr)

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Immunology 33%
2 drugs
Cardiovascular 17%
1 drugs
Neurology 17%
1 drugs
Infectious Disease 17%
1 drugs
Dermatology 17%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...